Topic

Articles

Law aims to mitigate ongoing global drug shortages. 

Citing Ongoing Drug Shortages, Biden Administration Invokes Defense Production Act

Researchers highlight steps to be taken in the European Union to manage the challenge of ongoing drug shortages.

The Impact of Drug Shortages Outside of the United States

IQVIA report explores why these shortages are increasing, and how they can be mitigated.

The Impact of US Drug Shortages on the Supply Chain

House Committee on Oversight and Accountability request documents on agency’s drug shortage mitigation strategies.

Congress Launches Investigation into FDA Drug Shortage Response 

Due to a higher than anticipated demand, Sanofi is carefully managing distribution of 50 mg doses of Beyfortus in the private market to fulfill existing orders and provide equitable access to remaining doses for the vaccine that protects infants against respiratory syncytial virus.

Sanofi Issues Update on Shortages of Beyfortus for Respiratory Syncytial Virus 

Mike Hollan is an assistant managing editor for 

 and can be reached at mhollan@mjhlifesciences.com.

Mangal discusses the causes of the shortage and how pharma companies can find solutions.

Battling the Cancer Drug Shortage: Q&A With Anshul Mangal, President of Project Farma and Precision Advance

Due to a global demand, treatments such as Adderall and Ritalin have been in short supply for the management of attention-deficit hyperactivity disorder. 

ADHD Drug Shortages: Causes, Implications, and Solutions 

Senior Vice President, Customer Success, FourKites

Increase in new treatments also brings increase in logistical challenges for pharma.

Shedding Light on Global Pharmaceutical Supply Chains

Julian Upton is a contributing editor for 

As borders shut down during the pandemic, pharma learned some lessons about sourcing.

Supply Chain Procurement

The 2013 Drug Supply Chain Security Act (DSCSA) established a framework for exchanging data when products are transacted throughout the US pharma supply chain. Its goal, by November 2023, is to enable unit-level traceability in a secure, interoperable manner. HDA’s Chip Davis talks about how pharma manufacturers must prepare for this implementation deadline.